ENCRYPTED SHIELD
Dead / Abandoned — Abandoned — failure to respond (as of 14 May 2024)
What this means for you
This application is over — abandoned 10 Apr 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97574537
- Mark type
- Stylized text
- Filed
- 01 Sept 2022
- Abandoned
- 10 Apr 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceuticals containing nucleic acids for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer; pharmaceutical preparations for the treatment of infectious diseases, viruses, immunological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, psychiatric diseases and disorders, respiratory diseases and disorders, genetic diseases and disorders, and cancer
Owner
- Autonomous Therapeutics, Inc., Rockville, MD, US
Prosecution history
- 14 May 2024 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 14 May 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 20 Dec 2023 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 20 Dec 2023 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 09 Oct 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Oct 2023 — NON-FINAL ACTION E-MAILED
- 09 Oct 2023 — NON-FINAL ACTION WRITTEN
- 13 Sept 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Sept 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Sept 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Jun 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Jun 2023 — NON-FINAL ACTION E-MAILED
- 19 Jun 2023 — NON-FINAL ACTION WRITTEN
- 18 Jun 2023 — ASSIGNED TO EXAMINER
- 20 Sept 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED